Nuwellis (CHFS) Competitors

Notice: This company has been marked as potentially delisted and may not be actively trading.

CHFS vs. TIVC, NUWE, NDRA, HSDT, PRFX, GLMD, BPTH, LSDI, CANOQ, and BJDX

Should you be buying Nuwellis stock or one of its competitors? The main competitors of Nuwellis include Tivic Health Systems (TIVC), Nuwellis (NUWE), ENDRA Life Sciences (NDRA), Helius Medical Technologies (HSDT), PainReform (PRFX), Galmed Pharmaceuticals (GLMD), Bio-Path (BPTH), Lucy Scientific Discovery (LSDI), Cano Health (CANOQ), and Bluejay Diagnostics (BJDX). These companies are all part of the "medical" sector.

Nuwellis vs.

Tivic Health Systems (NASDAQ:TIVC) and Nuwellis (NASDAQ:CHFS) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their earnings, profitability, media sentiment, analyst recommendations, institutional ownership, risk, valuation, community ranking and dividends.

Nuwellis has a net margin of -254.26% compared to Nuwellis' net margin of -701.02%. Tivic Health Systems' return on equity of -173.61% beat Nuwellis' return on equity.

Company Net Margins Return on Equity Return on Assets
Tivic Health Systems-701.02% -186.19% -138.20%
Nuwellis -254.26%-173.61%-131.01%

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Tivic Health Systems
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A
Nuwellis
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A

Tivic Health Systems has a beta of 2.88, suggesting that its share price is 188% more volatile than the S&P 500. Comparatively, Nuwellis has a beta of 1.55, suggesting that its share price is 55% more volatile than the S&P 500.

4.3% of Tivic Health Systems shares are held by institutional investors. Comparatively, 65.1% of Nuwellis shares are held by institutional investors. 2.7% of Tivic Health Systems shares are held by company insiders. Comparatively, 0.6% of Nuwellis shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Nuwellis received 324 more outperform votes than Tivic Health Systems when rated by MarketBeat users.

CompanyUnderperformOutperform
Tivic Health SystemsN/AN/A
NuwellisOutperform Votes
324
69.53%
Underperform Votes
142
30.47%

In the previous week, Tivic Health Systems had 2 more articles in the media than Nuwellis. MarketBeat recorded 2 mentions for Tivic Health Systems and 0 mentions for Nuwellis. Tivic Health Systems' average media sentiment score of 0.00 beat Nuwellis' score of -1.00 indicating that Nuwellis is being referred to more favorably in the news media.

Company Overall Sentiment
Tivic Health Systems Negative
Nuwellis Neutral

Tivic Health Systems has higher earnings, but lower revenue than Nuwellis. Tivic Health Systems is trading at a lower price-to-earnings ratio than Nuwellis, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Tivic Health Systems$1.18M1.30-$8.24M-$42.48-0.02
Nuwellis$5.51M0.18-$18.11M-$279.280.00

Summary

Nuwellis beats Tivic Health Systems on 8 of the 14 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CHFS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CHFS vs. The Competition

MetricNuwellisElectromedical Equipment IndustryMedical SectorNASDAQ Exchange
Market Cap$1.01M$2.95B$4.65B$7.58B
Dividend YieldN/A1.74%5.35%3.94%
P/E Ratio0.0010.28173.2915.53
Price / Sales0.1859.292,439.4384.84
Price / CashN/A53.9144.9333.98
Price / Book0.013.594.624.50
Net Income-$18.11M$82.04M$98.68M$211.97M

Nuwellis Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
TIVC
Tivic Health Systems
0 of 5 stars
$1.13
-3.4%
N/A-92.5%$1.66M$1.18M-0.039Short Interest ↑
Gap Up
NUWE
Nuwellis
0.3283 of 5 stars
$0.30
-11.9%
N/A-96.6%$2.02M$8.86M-0.0259Gap Up
High Trading Volume
NDRA
ENDRA Life Sciences
0 of 5 stars
$0.25
flat
N/A-84.2%$2.81MN/A-0.1321Gap Up
HSDT
Helius Medical Technologies
1.2236 of 5 stars
$4.90
-3.4%
$54.50
+1,012.2%
-53.6%$4.36M$640,000.00-0.3426Gap Down
PRFX
PainReform
0 of 5 stars
$0.89
+4.7%
N/A-85.7%$1.81MN/A0.007Short Interest ↑
GLMD
Galmed Pharmaceuticals
0 of 5 stars
$0.36
flat
N/A-91.6%$1.83MN/A-0.114Short Interest ↑
BPTH
Bio-Path
2.7239 of 5 stars
$2.69
-7.9%
$40.00
+1,389.8%
-90.5%$1.83MN/A-0.0710Short Interest ↓
Gap Down
LSDI
Lucy Scientific Discovery
0 of 5 stars
$1.05
-7.1%
N/A-93.8%$1.85M$10,000.00-0.152Short Interest ↓
CANOQ
Cano Health
0 of 5 stars
$0.35
+40.0%
N/AN/A$1.89M$3.14B0.002,700Gap Up
BJDX
Bluejay Diagnostics
0 of 5 stars
$0.63
+1.6%
N/A-89.3%$1.68M$250,000.00-0.0710Positive News

Related Companies and Tools

This page (NASDAQ:CHFS) was last updated on 4/29/2024 by MarketBeat.com Staff

From Our Partners